Our Solutions
Our portfolio gives you access to relevant data insights from across the pharmaceutical markets.
Learn more
About Us
Publications
Produktlebenszyklus
Insights Across the Entire Product Life Cycle – Data-driven Life Cycle Management
Insight Health supports you in every phase of the product life cycle. Our experienced market research experts leverage robust data to deliver a comprehensive analysis of the market and generate valuable insights for the pre-launch, launch, and post-launch stages. This enables you to make well-informed decisions for the commercialization of your medicinal product.
We support you throughout your product launch and beyond – and identify opportunities for the first best action for your sales force.
Product life cycle
We Deliver Insights for Every Phase of the
Product Life Cycle
In the pre-launch phase, the focus is on conducting a comprehensive market analysis and preparing for market entry. We support you from patient recruitment and market and target group analysis all the way through to targeting and the segmentation of sales force territories.
As you move into the launch phase, we remain at your side with a tailored launch support package that combines data-driven monitoring with tightly managed sales force steering. This helps you successfully position your new prescription drug (Rx) and fully realize its market potential.
Post-launch, we provide continuous monitoring, support the optimization of your sales and marketing strategy, and capture the most relevant KPIs, preparing them in clear, compelling visual dashboards and graphics.
Together with our group subsidiary intermedix, we also offer solutions for physician communication, ensuring that your target audience remains highly engaged throughout your product’s growth and maturity phases.
When your product reaches loss of exclusivity (LOE) or patent expiry, our data and analytics enable targeted life cycle management to help you manage the transition strategically and sustainably.
Pre-Launch
Data-driven launch support
The better a market entry is prepared, the more successful it will be. Our market analyses make the difference for your launch excellence. With detailed insights into market size, market growth, market forecasts, the competitive landscape, and untapped potential, you can make confident, well-founded decisions.
Market analysis / pre-assessment
With our insights and market reports, you have market size, market growth, forecasts, competition, and potential clearly in view as part of a pre-assessment. These are based on NVI (National SHI billing data), pharmacy panel data, data from pharmacy billing centers, as well as sell-in data from pharmaceutical wholesale.
Target audience analysis
Our target audience analyses provide the key insights you need for a successful launch and deliver a detailed view of physician practices, community pharmacies, and patients. This allows you to define and refine your target group with maximum precision. In addition, you benefit from essential information to steer your sales force and optimize your overall marketing strategy.
Targeting
In the area of targeting, we offer tailored solutions for every audience – from pharmacy targeting and patient profiles to physician targeting. We identify high-potential regions even before your product enters the market, as well as early adopters among physicians who prescribe shortly after launch. This enables you to fully identify and capture your product’s maximum potential.
Field force planning / territory alignment
We design a balanced territory structure for your sales force. Based on our analyses of potential, workload, and field force availability, we develop tailor-made structural models for your specific needs. These models ensure fair allocation of sales opportunities, a focused approach to high-potential targets, and stronger customer centricity.
Patient recruitment
When a patient meets the study criteria, a search algorithm in the medical practice software triggers a prominent alert informing the physician that the patient is eligible for participation. This alert appears either when the patient record is opened or when a diagnosis is entered. Conducting this pre-screening during the visit makes it significantly easier for you to recruit qualified patient groups.
Launch
Launchtracking / live monitoring
Throughout the go-to-market phase, you need to keep a close eye on all key performance indicators (KPIs) and market dynamics. Insight Health provides monitoring based on daily data (pharmacy panel) and weekly data (pharmaceutical wholesale and pharmacy panel). This makes launch tracking easier and ensures continuous monitoring of your product and activities. In this way, you gain essential, data-driven insights to optimize your marketing and sales strategy.
Tight, continuous sales force management
Highly granular territory structures and cluster analyses enable you to deploy your sales force in a targeted way and track performance over time. This allows you to identify patterns more quickly, optimize field time, shorten travel distances, and gain a deeper understanding of weekly developments. In addition, your sales force can react to local changes in real time—keeping you one step ahead of the competition.
Patient journey & source of business analyses
We deliver answers to complex patient-related questions: Insight Health leverages anonymized data from around 80% of German statutory health insurance (SHI) patients to generate robust, trustworthy results. With a broad range of analyses – including interdisciplinary and longitudinal patient journeys, therapy support, and compliance – we provide detailed insights into target patient populations and real-world treatment patterns.
Post-Launch
Impact tracking
A combination of weekly data and the physician’s prescribing behavior enables timely analysis of the effectiveness of your marketing mix. In a dedicated dashboard, your campaign performance can be compared with similar competitor campaigns, allowing you to extract new insights to further optimize your marketing strategy.
Continuous sales management & incentive programs
Close alignment with your sales force enables seamless coordination between sales and marketing. This increases the impact of your product launch and drives rapid market growth. With regional SHI billing data, you can effectively manage and evaluate the performance of your sales force in the statutory health insurance (SHI) market.
Business intelligence / dashboarding
With the right business intelligence tools and processes, you can boost your long-term profitability and strengthen your competitive position. Our comprehensive, tailored BI solutions help you do exactly that by turning your data into actionable insights. We also take care of presenting complex data in a clear, compelling visual format for you.
Retargeting & territory realignment
Retargeting is about using insights into your target audience to reach them in a highly targeted way across multiple channels – to build awareness, stimulate purchases, or win back former customers. Combined with an adjustment of your territory structures (realignment), you can keep your target audience focused on your product well beyond launch and more effectively steer your sales force activities.
Substitution
The Substitution Monitor combines the pharmaceutical registration number (PZN) prescribed by the physician with the PZN actually dispensed by the community pharmacy, bringing together both perspectives in a single database. This gives you powerful analytics capabilities that provide full transparency from the prescription at the physician level through to billing data, delivering valuable insights to support optimization for you as the original manufacturer.
Analysis of patient flows / patient tracking
Anonymized healthcare services data from medical practice software and pharmacy billing centers can provide interdisciplinary insights into the patient journey, co-medication, and therapy. Combined with data on diagnoses, lab values, and treatment regimens, it becomes possible to analyze treatment adherence (adherence, persistence), treatment progress, and patient flows. This gives you a deep understanding of both the physicians’ perspective and the patients’ experience.
Life Cycle Management
Patent data
With the pharmaceutical patent database Shark, you receive ongoing updates on, for example, EMA approvals and gain access to patent data from 29 countries (Europe, North America, Japan) that together account for around 85 percent of the global market. Regular updates ensure the validity of patent and SPC information. With Shark, you can closely monitor market and competitive developments and leverage these insights for your strategic planning.
Country-of-origin analysis
This analysis identifies the countries of origin of the reimports distributed in Germany. By monitoring product flows over an extended period, developments can be mapped as part of life cycle management. To do this, the batch numbers of the reimport PZNs under review are captured within the inventories of the full-range pharmaceutical wholesale sector.
Tender management
Statutory health insurance companies tender a large share of their demand for prescription drugs as generics and biosimilars. By combining rebate contract tenders with SHI billing data, you can extract valuable insights into the number of discounted prescriptions, “aut idem” substitutions, and non-performance. With our up-to-date tender database, you also keep track of contract durations, new tenders, and price changes on a daily basis.
